EG Labs Announces Recall of Viapro 375 mg Capsules

EG Labs, LLC announced a nationwide voluntary recall of all lots of its supplement sold under the brand name Viapro, in 375mg capsules.

The company announced the recall after lab analysis by the U.S. Food and Drug Administration (FDA) found the product contained a potentially harmful undeclared ingredient, thio-methisosildenafil.

Thio-methisosildenafil is an analog of sildenafil, which is an active chemical ingredient of an FDA-approved drug used for the treatment of Erectile Dysfunction in men.

The use of undeclared chemicals pose a threat to consumers because they may harmfully interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take such nitrates.

Consumers are advised to stop use immediately and to contact their medical doctor if they experience any adverse effects associated with use. Consumers can send the product back to the company for a full refund at the following address: Seaboard Tampa Terminal: 6708 Harney Road Tampa Florida, 33610.

Any adverse events that may be related to the use of this product should be reported to the FDA’s MedWatch Program by phone at 1-800-FDA-1088 or by fax at 1-800-FDA-0178 or by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or online.